{"id":"3a3dc67c-0ab7-4617-b85f-14deec3b3382","slug":"primary-midbrain-germinoma-relapse-free-for-5-years-a-case-report","title":"Primary midbrain germinoma relapse-free for 5 years: A case report","authors":["Akito Oshima","Toshikazu Kimura","Atsuya Akabane","Tomohiro Inoue"],"abstract":"Background: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. Case Description: A 39-year-old man who had been diagnosed with midbrain germinoma by open biopsy through the occipital transtentorial approach had undergone chemoradiotherapy and achieved 5 years with no recurrence. Conclusion: Germinomas should be considered as a differential diagnosis for adolescents and young adult men with mesencephalic tumors, and reliable sampling followed by chemoradiotherapy must be performed.","thumbnailUrl":"https://sni-digital-videos.s3.amazonaws.com/articles/3a3dc67c-0ab7-4617-b85f-14deec3b3382/featured/hero-1781560663475.png","publishDate":"2022-12-09T00:00:00.000Z","doi":"10.25259/SNI_703_2022","categories":["Neuro-oncology","Case Report"],"fullTextUrl":"https://surgicalneurologyint.com/wp-content/uploads/2022/12/12049/SNI-13-574.pdf"}